Roche Holding Operating Margin Over Time

Stocks . Switzerland . 
Stock . Roche Holding AG
RO Stock  CHF 368.00  8.00  2.22%   
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Roche Holding Performance and Roche Holding Correlation.
  
At this time, Roche Holding's Cash Per Share is fairly stable compared to the past year. Tangible Book Value Per Share is likely to climb to 15.81 in 2026, whereas Common Stock Shares Outstanding is likely to drop slightly above 680.1 M in 2026.
Altman
Z Score
Details
Intrinsic
Valuation
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Earnings
Projections
Details
It's important to distinguish between Roche Holding's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Roche Holding should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Roche Holding's market price signifies the transaction level at which participants voluntarily complete trades.
Apply

Cross Equities Operating Profit Margin Analysis

Compare Roche Holding AG and related stocks such as Novartis AG, COSMO Pharmaceuticals, and Siegfried Holding Operating Margin Over Time
Select Fundamental
Price To Sales RatioDividend Yield
Ptb RatioDays Sales Outstanding
Book Value Per ShareFree Cash Flow Yield
Invested CapitalOperating Cash Flow Per Share
Average PayablesStock Based Compensation To Revenue
Capex To DepreciationPb Ratio
Ev To SalesFree Cash Flow Per Share
RoicInventory Turnover
Net Income Per ShareDays Of Inventory On Hand
Payables TurnoverSales General And Administrative To Revenue
Average InventoryResearch And Ddevelopement To Revenue
Capex To RevenueCash Per Share
PocfratioInterest Coverage
Payout RatioCapex To Operating Cash Flow
Pfcf RatioDays Payables Outstanding
Net Current Asset ValueIncome Quality
RoeTangible Asset Value
Ev To Operating Cash FlowPe Ratio
Return On Tangible AssetsEv To Free Cash Flow
Earnings YieldIntangibles To Total Assets
Net Debt To E B I T D ACurrent Ratio
Tangible Book Value Per ShareReceivables Turnover
Graham NumberShareholders Equity Per Share
Debt To EquityCapex Per Share
Graham Net NetAverage Receivables
Revenue Per ShareInterest Debt Per Share
Debt To AssetsEnterprise Value Over E B I T D A
Short Term Coverage RatiosPrice Earnings Ratio
Operating CyclePrice Book Value Ratio
Price Earnings To Growth RatioDays Of Payables Outstanding
Dividend Payout RatioPrice To Operating Cash Flows Ratio
Price To Free Cash Flows RatioPretax Profit Margin
Ebt Per EbitOperating Profit Margin
Effective Tax RateCompany Equity Multiplier
Long Term Debt To CapitalizationTotal Debt To Capitalization
Return On Capital EmployedDebt Equity Ratio
Ebit Per RevenueQuick Ratio
Dividend Paid And Capex Coverage RatioNet Income Per E B T
Cash RatioCash Conversion Cycle
Operating Cash Flow Sales RatioDays Of Inventory Outstanding
Days Of Sales OutstandingFree Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage RatiosPrice To Book Ratio
Fixed Asset TurnoverCapital Expenditure Coverage Ratio
Price Cash Flow RatioEnterprise Value Multiple
Debt RatioCash Flow To Debt Ratio
Price Sales RatioReturn On Assets
Asset TurnoverNet Profit Margin
Gross Profit MarginPrice Fair Value
Return On Equity
20102011201220132014201520162017201820192020202120222023202420252026
NOVN0.21830.18160.22140.20830.20680.17820.16720.20050.18230.18670.20350.22870.18280.20940.28120.31150.17
COPN(0.0536)0.29660.44430.22950.27914.12990.3104(0.2305)(0.2533)(0.1969)0.11330.17060.27480.06620.55810.50.26
SFZN0.1890.03540.04870.08760.08420.08520.05590.08240.09770.06580.09160.11790.18510.13530.15390.140.15
SOON0.10380.17760.08730.20740.20840.18720.17810.18710.19680.17520.23810.23340.20380.18470.1790.160.15
GALE0.04020.04020.04020.04020.04020.04070.04120.04160.03330.04940.05810.04860.04810.05110.05210.04690.0366
ALC0.06150.06150.06150.06150.06150.06150.0015(0.0113)(0.0347)(0.0249)(0.0705)0.070.07710.10990.14260.130.13
TECN0.13460.1360.13370.14030.14430.1520.13560.1490.14720.13960.16830.14910.12760.12660.08090.07280.1
CLTN0.09270.08380.10770.12150.1380.13190.14510.15170.11610.11690.09370.15680.13070.08080.10730.09660.096

Roche Holding AG and related stocks such as Novartis AG, COSMO Pharmaceuticals, and Siegfried Holding Operating Profit Margin description

My Equities

My Current Equities and Potential Positions

View AllNext
Roche Holding AG
RO
Specialization
Health Care, Pharmaceuticals, Biotechnology & Life Sciences
Business AddressGrenzacherstrasse 124, Basel,
ExchangeSIX Swiss Exchange
CHF 368.0

Additional Tools for Roche Stock Analysis

When running Roche Holding's price analysis, check to measure Roche Holding's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Roche Holding is operating at the current time. Most of Roche Holding's value examination focuses on studying past and present price action to predict the probability of Roche Holding's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Roche Holding's price. Additionally, you may evaluate how the addition of Roche Holding to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY